Literature DB >> 23571465

GC-MS-based urine metabolic profiling of autism spectrum disorders.

Patrick Emond1, Sylvie Mavel, Nacima Aïdoud, Lydie Nadal-Desbarats, Frédéric Montigny, Frédérique Bonnet-Brilhault, Catherine Barthélémy, Marc Merten, Pierre Sarda, Frédéric Laumonnier, Patrick Vourc'h, Hélène Blasco, Christian R Andres.   

Abstract

Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders resulting from multiple factors. Diagnosis is based on behavioural and developmental signs detected before 3 years of age, and there is no reliable biological marker. The purpose of this study was to evaluate the value of gas chromatography combined with mass spectroscopy (GC-MS) associated with multivariate statistical modeling to capture the global biochemical signature of autistic individuals. GC-MS urinary metabolic profiles of 26 autistic and 24 healthy children were obtained by liq/liq extraction, and were or were not subjected to an oximation step, and then were subjected to a persilylation step. These metabolic profiles were then processed by multivariate analysis, in particular orthogonal partial least-squares discriminant analysis (OPLS-DA, R(2)Y(cum) = 0.97, Q(2)(cum) = 0.88). Discriminating metabolites were identified. The relative concentrations of the succinate and glycolate were higher for autistic than healthy children, whereas those of hippurate, 3-hydroxyphenylacetate, vanillylhydracrylate, 3-hydroxyhippurate, 4-hydroxyphenyl-2-hydroxyacetate, 1H-indole-3-acetate, phosphate, palmitate, stearate, and 3-methyladipate were lower. Eight other metabolites, which were not identified but characterized by a retention time plus a quantifier and its qualifier ion masses, were found to differ between the two groups. Comparison of statistical models leads to the conclusion that the combination of data obtained from both derivatization techniques leads to the model best discriminating between autistic and healthy groups of children.

Entities:  

Mesh:

Year:  2013        PMID: 23571465     DOI: 10.1007/s00216-013-6934-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  35 in total

1.  The Brain-Gut-Microbiome Axis: What Role Does It Play in Autism Spectrum Disorder?

Authors:  Ruth Ann Luna; Tor C Savidge; Kent C Williams
Journal:  Curr Dev Disord Rep       Date:  2016-02-26

Review 2.  Autism spectrum disorders and intestinal microbiota.

Authors:  Maria De Angelis; Ruggiero Francavilla; Maria Piccolo; Andrea De Giacomo; Marco Gobbetti
Journal:  Gut Microbes       Date:  2015

3.  A Subset of Patients With Autism Spectrum Disorders Show a Distinctive Metabolic Profile by Dried Blood Spot Analyses.

Authors:  Rita Barone; Salvatore Alaimo; Marianna Messina; Alfredo Pulvirenti; Jean Bastin; Alfredo Ferro; Richard E Frye; Renata Rizzo
Journal:  Front Psychiatry       Date:  2018-12-07       Impact factor: 4.157

Review 4.  The gut microbiota-brain axis in behaviour and brain disorders.

Authors:  Livia H Morais; Henry L Schreiber; Sarkis K Mazmanian
Journal:  Nat Rev Microbiol       Date:  2020-10-22       Impact factor: 60.633

5.  Potential serum biomarkers from a metabolomics study of autism.

Authors:  Han Wang; Shuang Liang; Maoqing Wang; Jingquan Gao; Caihong Sun; Jia Wang; Wei Xia; Shiying Wu; Susan J Sumner; Fengyu Zhang; Changhao Sun; Lijie Wu
Journal:  J Psychiatry Neurosci       Date:  2016-01       Impact factor: 6.186

6.  In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D.

Authors:  Afaf El-Ansary; John J Cannell; Geir Bjørklund; Ramesa Shafi Bhat; Abeer M Al Dbass; Hanan A Alfawaz; Salvatore Chirumbolo; Laila Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2018-03-01       Impact factor: 3.584

Review 7.  Advances in the design of nanomaterial-based electrochemical affinity and enzymatic biosensors for metabolic biomarkers: A review.

Authors:  Leila Farzin; Mojtaba Shamsipur; Leila Samandari; Shahab Sheibani
Journal:  Mikrochim Acta       Date:  2018-05-02       Impact factor: 5.833

Review 8.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

Review 9.  Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.

Authors:  Marc-Emmanuel Dumas; Laetitia Davidovic
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-24       Impact factor: 4.147

10.  Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder.

Authors:  Brittany D Needham; Mark D Adame; Gloria Serena; Destanie R Rose; Gregory M Preston; Mary C Conrad; A Stewart Campbell; David H Donabedian; Alessio Fasano; Paul Ashwood; Sarkis K Mazmanian
Journal:  Biol Psychiatry       Date:  2020-10-10       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.